Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 21 15630 78731 94031 414--
Entreprise Value (EV)1 29 55238 39039 26437 79036 21634 823
P/E ratio -55,8x27,4x-230x33,3x25,3x23,1x
Yield 0,93%0,64%0,62%0,64%0,67%0,67%
Capitalization / Revenue 2,67x3,86x4,55x3,90x3,71x3,55x
EV / Revenue 3,73x4,81x5,59x4,69x4,27x3,94x
EV / EBITDA 11,1x14,7x19,2x14,5x12,7x11,5x
Price to Book 1,88x2,49x2,62x2,41x2,01x1,85x
Nbr of stocks (in thousands) 203 976205 684207 278208 840--
Reference price (USD) 104150154150150150
Announcement Date 02/01/201902/04/202002/05/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 7 9337 9827 0258 0658 4758 848
EBITDA1 2 6552 6102 0442 6062 8613 032
Operating profit (EBIT)1 2 2102 1891 6092 1452 3802 558
Operating Margin 27,9%27,4%22,9%26,6%28,1%28,9%
Pre-Tax Profit (EBT)1 -271906-2741 3161 5731 795
Net income1 -3791 132-1399671 2851 432
Net margin -4,78%14,2%-1,98%12,0%15,2%16,2%
EPS2 -1,865,47-0,674,525,946,52
Dividend per Share2 0,960,960,960,961,001,01
Announcement Date 02/01/201902/04/202002/05/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 2 0851 8472 0271 9522 2452 029
EBITDA1 682590642613758683
Operating profit (EBIT)1 565476530502642548
Operating Margin 27,1%25,8%26,2%25,7%28,6%27,0%
Pre-Tax Profit (EBT)1 196221174220385224
Net income1 334198142202324268
Net margin 16,0%10,7%7,00%10,4%14,4%13,2%
EPS2 1,590,940,671,001,571,29
Dividend per Share ------
Announcement Date 02/05/202105/04/202108/03/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 8 3967 6047 3246 3774 8023 409
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,16x2,91x3,58x2,45x1,68x1,12x
Free Cash Flow1 1 3081 0637958191 7081 966
ROE (Net Profit / Equities) 13,6%13,7%9,61%11,4%11,5%11,7%
Shareholders' equity1 -2 7878 234-1 4458 48911 15312 276
ROA (Net Profit / Asset) 6,24%6,67%4,82%6,29%6,95%7,63%
Assets1 -6 07316 965-2 88315 38018 50818 755
Book Value Per Share2 55,360,158,762,474,781,2
Cash Flow per Share2 8,597,675,828,8411,312,1
Capex1 439523409467492507
Capex / Sales 5,53%6,55%5,83%5,80%5,81%5,72%
Announcement Date 02/01/201902/04/202002/05/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 31 413 787 408
Net sales (USD) 7 024 500 000
Number of employees 20 000
Sales / Employee (USD) 351 225
Free-Float 66,7%
Free-Float capitalization (USD) 20 967 235 893
Avg. Exchange 20 sessions (USD) 177 241 428
Average Daily Capital Traded 0,56%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA